| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.0046 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.0021 | 1 |